All Industries

Top Life Sciences Companies

1,069 Life Sciences companies, sorted by total funding raised.

Ironwood PharmaceuticalsIPO

Ironwood Pharmaceuticals is a Boston-based GI-focused biopharmaceutical company that develops and...

Boston, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$175.0MFeb 2019
Variant Bio

Variant Bio develops life-saving therapies by studying the genetics of people with exceptional he...

Seattle, United States11–50Life Sciences
Corporate RoundTotal funding$171.0MJan 2025
AviadoBio

AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerati...

London, United Kingdom51–200Biotech, Genomics
Series BTotal funding$168.5MApr 2025
Well

AI-driven health engagement platform for employers, using personalized interventions, incentives,...

Chapel Hill, United States201–500Life Sciences, Artificial Intelligence
Series BTotal funding$165.0MJan 2025
Vizgen

Life sciences company developing spatial biology and multi-omics platforms to map gene and protei...

Cambridge, United States51–200Biotech, Life Sciences
Series CTotal funding$158.2MJun 2022
Third Harmonic BioIPO

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor the...

Boston, United StatesLife Sciences
Series BTotal funding$155.0MDec 2021
EpizymeIPO

Biopharmaceutical company that is creating innovative drugs for major diseases based on important...

Cambridge, United States201–500Biotech, Drug Discovery
Growth EquityTotal funding$154.0MNov 2019
SciNeuro

SciNeuro is a clinical-stage biotechnology company that develops innovative medicines for patient...

Shanghai, China11–50Life Sciences, Biotech
Series BTotal funding$153.0MDec 2025
Equip Health

Equip Health provides virtual, insurance-covered, family-based eating disorder treatment, pairing...

San Diego, United States501–1000Life Sciences, Healthcare
Series DTotal funding$152.6MJul 2025
ElektrofiAcquired

Develops Hypercon hyper-concentrated microparticle formulations to enable subcutaneous delivery o...

Boston, United States51–200Life Sciences, Biotech
Series CTotal funding$152.3MOct 2024
Avencell

AvenCell is a clinical-stage cell therapy company developing controllable, allogeneic CAR-T thera...

Watertown, United States51–200Biotech, Genomics
GrantTotal funding$152.0MJun 2025
SeLux Diagnostics, Inc.

Selux Diagnostics develops a Next Generation Phenotyping platform that speeds personalized antibi...

Charlestown, United States1–10Diagnostics, Healthcare
Series DTotal funding$151.4MMar 2024
MasterControl

MasterControl helps life sciences manufacturers develop, manufacture, and commercialize products ...

Salt Lake City, United States501–1000Life Sciences, SaaS
Growth EquityTotal funding$150.0MDec 2022
Profluent

Born out of pioneering research in artificial intelligence and biology, Profluent Bio develops ma...

Berkeley, United States11–50Life Sciences, Artificial Intelligence
Series BTotal funding$150.0MNov 2025
Zarminali Pediatrics

Zarminali Pediatrics is a nationwide pediatric multispecialty group providing coordinated primary...

Chicago, United States51–200Life Sciences, Healthcare
Series ATotal funding$150.0MJan 2026
Impel PharmaceuticalsIPO

Impel Pharmaceuticals is a commercial-stage biopharmaceutical company developing transformative t...

Keller, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$148.5MSep 2021
Corvia

Develops the Corvia Atrial Shunt, a transcatheter implant for HFpEF and HFmrEF, used by hospitals...

Tewksbury, United States11–50Life Sciences, Hardware
Series FTotal funding$144.0MJun 2025
Automata

Automata builds the LINQ lab automation platform so life-science labs can run genomics, cell biol...

London, United Kingdom51–200Artificial Intelligence, Life Sciences
Series CTotal funding$142.4MJan 2026
Mersana TherapeuticsIPO

Mersana Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conju...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$136.1MJun 2016
Akero TherapeuticsAcquired

Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patie...

South San Francisco, United StatesLife Sciences
Series BTotal funding$135.0MDec 2018
SalioGen Therapeutics
Biotech, Genomics
Series BTotal funding$135.0MJan 2022
Ossium Health

Bioengineering company building the world's first bone marrow bank to enable on-demand stem cell ...

San Francisco, United States51–200Life Sciences, Biotech
GrantTotal funding$131.0MAug 2024
CHARM Therapeutics

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

London, United Kingdom11–50Life Sciences, Biotech
Series BTotal funding$130.0MSep 2025
Science 37Acquired

Operates an FDA-inspected direct-to-patient clinical trial site that enables sponsors to run dece...

Los Angeles, United States201–500Digital Health, Healthcare
Venture RoundTotal funding$129.5MAug 2020
Nautilus BioIPO

Biotechnology company developing a single-molecule proteomics platform to identify and quantify p...

San Diego, United States51–200Biotech, Artificial Intelligence
Corporate RoundTotal funding$128.3MJul 2021